DNA2.0 Announces Opening of European Office
"We are excited to enhance DNA2.0's custom gene synthesis services in the European marketplace," said Dr. Jeremy Minshull, President of DNA2.0. "We have devoted our energies to building the fastest and most reliable gene synthesis process in the world. Our Basel office will allow us to provide the same PhD-level customer support to our growing European customer base that our US customers already enjoy."
"Our investment in Europe reflects the strong growth we see in demand for synthetic genes at European biotechnology and pharmaceutical companies as well as its universities," said Dr. Louise Rafty, Director of Sales at DNA2.0. "Access to fast and accurate gene synthesis is revolutionizing the way scientists think about molecular biology; enabling a number of exciting emerging applications such as codon optimization, protein engineering, and RNAi resistance."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.